Bumetanide Oral Solution
Bumetanide is an oral liquid medicine used to treat Oedema.
Bumetanide is indicated for:
Whenever diuretic therapy is required in the treatment of oedema, e.g. that associated with congestive heart failure, cirrhosis of the liver and renal disease including nephrotic syndrome.
Summary of Product Characteristics
Read this summary of product characteristics for further information about Bumetanide Liquid Oral Solution. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Bumetanide Liquid Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.
Bumetanide Oral Solution
Click here for Audio Version | |
Flavour | Peppermint |
Storage Conditions | Store below 25°C |
Sucrose Free | |
Shelf Life (Closed Bottle) | 3 years |
PIP Code | 1142637 |
EAN Code | 5016119000782 |
Sodium Levels | Essentially sodium-free |
Ethanol Concentration | None |
Downloads
Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
Adverse events should also be reported to Rosemont at 0113 244 1400 or pharmacovigilance@rosemontpharma.com.
Contact us
For further product information and pricing please use the form below and a member of the team will be in touch
[contact-form-7 id="275" title="Contact form 1" html_class="two-col-contact-form"]Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.